persist
infect
highrisk
human
papilloma
viru
hpv
primari
caus
cervic
intraepitheli
neoplasia
cin
cervic
carcinoma
third
common
hpv
genotyp
china
hpv
oncoprotein
constitut
express
hpvassoci
cancer
cell
therefor
consid
ideal
target
antigen
immunotherapi
includ
hpv
therapeut
vaccin
present
studi
human
leukocyt
antigen
hla
cytotox
lymphocyt
ctl
epitop
peptid
predict
screen
antigen
immunogen
subsequ
determin
total
peptid
deriv
predict
select
use
differ
predict
program
neg
control
peptid
pb
use
two
neg
control
peripher
blood
mononuclear
cell
pbmc
allel
use
detect
specif
cellular
immun
respons
among
predict
peptid
enzymelink
immunospot
assay
elisopt
follow
preliminari
screen
predict
peptid
antigen
peptid
assess
immunoassay
vaccin
contain
antigen
specif
humor
cellular
immun
detect
use
peptid
specif
antigen
total
peptid
protein
predict
subsequ
cervic
cancer
second
common
femal
malign
tumor
follow
breast
cancer
high
risk
human
papilloma
viru
hpv
confirm
domin
factor
respons
sever
anogenit
diseas
particularli
cervic
intraepitheli
neoplasia
cin
cervic
carcinoma
two
hundr
hpv
genotyp
six
particularli
import
highli
correl
cervic
carcinoma
case
persist
infect
high
risk
hpv
primari
factor
respons
cervic
cancer
although
strain
two
common
highrisk
hpv
genotyp
worldwid
genotyp
distribut
studi
chines
women
shown
third
common
genotyp
found
chines
cervic
carcinoma
patient
infect
common
western
countri
current
domest
foreign
research
lack
howev
high
rate
infect
china
firmli
indic
studi
investig
therapeut
vaccin
necessari
hpv
earli
oncoprotein
hpv
continu
present
cervic
cancer
cell
protein
respons
carcinogen
hpv
mani
studi
show
sustain
express
oncoprotein
necessari
tumorigen
develop
cervic
cancer
cell
accordingli
hpv
could
appli
target
antigen
candid
hpv
therapeut
vaccin
due
constitut
express
mainten
cellular
transform
hpvinfect
cell
continu
express
imposs
cervic
carcinoma
cell
invok
immunolog
escap
antigen
loss
date
extens
confirm
ideal
target
antigen
develop
hpv
therapeut
vaccin
hpvrelat
cin
cervic
carcinoma
hpv
therapeut
vaccin
design
use
specif
epitop
peptid
target
antigen
induc
specif
cellular
immun
respons
avoid
immunosuppress
induc
natur
protein
enhanc
immun
specif
immun
effect
present
type
vaccin
becom
focu
research
immun
field
recent
research
found
cytotox
lymphocyt
ctl
epitop
oncoprotein
match
human
leukocyt
antigen
hla
current
consid
common
human
major
histocompat
complex
mhc
molecul
immunogen
epitop
confirm
use
transgen
mice
vitro
lymphocyt
human
peripher
blood
previous
immun
polypeptid
vaccin
induc
specif
ctl
immun
respons
kill
tumor
cell
howev
ctl
epitop
found
view
high
infect
rate
china
attempt
find
specif
ctl
epitop
antigen
protein
prepar
correspond
polypeptid
vaccin
treat
cervic
cancer
achiev
goal
screen
ctl
epitop
peptid
evalu
immun
respons
result
epitop
peptid
may
serv
candid
epitop
prepar
therapeut
epitop
peptid
vaccin
peptid
predict
synthesi
fulllength
amino
acid
sequenc
access
protein
obtain
genbank
protein
compos
amino
acid
seq
uenc
follow
mrg
nnp
tlr
eyi
ldl
hpe
ptd
lfc
yeq
lcd
ssd
ede
igl
drp
dgq
aqp
ata
nyy
ivt
cci
tcg
ttv
rlc
in
ttt
dvr
tlq
qll
mgt
cti
vcp
sca
qq
predict
peptid
use
identif
ctl
epitop
select
basi
differ
predict
program
internet
websit
includ
hla
bind
peptid
predict
http
wwwbimascitnihgovmolbiohla
bind
syfpeithi
http
wwwsyfpeithidescriptsmhcserv
dllepitop
predictionhtm
mhc
class
ibind
predict
use
artifici
neural
network
http
toolsimmun
epitopeorganalyzehtmlmhci
bind
bind
html
predict
peptid
contain
nine
amino
acid
synthes
solid
phase
peptid
synthesi
purifi
reversedphas
high
perform
liquid
chromatographi
abgent
san
diego
ca
usa
neg
control
peptid
irrelev
peptid
sar
coronaviru
cov
spike
protein
lyltqdlfl
synthes
purifi
way
gl
biochem
co
ltd
shanghai
china
mass
peptid
mg
puriti
exceed
total
ml
peripher
blood
healthi
women
volunt
drawn
vacuum
bag
basil
vein
studi
use
volunt
sampl
approv
ethic
committe
guangxi
medic
univers
affili
tumor
hospit
written
inform
consent
obtain
volunt
human
pbmc
separ
peripher
blood
use
ficol
densiti
gradient
separ
method
final
concentr
pbmc
dilut
contain
fb
final
volum
ad
well
ul
cell
inocul
cultur
plate
stimul
six
predict
peptid
neg
control
peptid
respect
time
cell
ad
uml
interleukin
everi
day
three
time
stimul
peptid
pbmc
collect
eilspot
elispot
assay
human
pbmc
human
pbmc
activ
predict
peptid
neg
control
peptid
detect
special
immun
spot
elispot
kit
dakew
biotech
co
ltd
shenzhen
china
briefli
nitrocellulos
plate
precoat
antihuman
interferon
ifn
antibodi
place
overnight
block
follow
day
medium
contain
fb
pbmc
ad
well
concentr
cellswel
volum
cell
stimul
six
predict
peptid
neg
control
peptid
pha
ngml
sigmaaldrich
merck
kgaa
darmstadt
germani
pb
respect
pha
serv
posit
control
neg
control
peptid
pb
serv
neg
control
plate
incub
carbon
dioxid
h
next
day
plate
incub
biotinyl
antihuman
antibodi
primari
antibodi
h
room
temperatur
unbound
primari
antibodi
remov
wash
scrub
solut
streptavidinhrp
antibodi
secondari
antibodi
ad
follow
h
incub
room
temperatur
unbound
secondari
antibodi
remov
wash
scrub
solut
stain
aec
substrat
solut
carri
min
plate
wash
air
dri
h
immun
spot
repres
individu
cell
spotform
cell
sfc
membran
enumer
kselispot
automat
system
dakew
biotech
co
ltd
respons
consid
posit
associ
spot
number
produc
predict
peptid
stimul
sfcwell
compar
respons
obtain
neg
control
peptid
pvalu
consid
signific
antigen
verif
peptid
immun
evalu
peptid
stttdvrtl
mice
cervic
cancer
cell
line
adenoviru
vector
vaccin
contain
antigen
construct
author
anim
experi
approv
ethic
committe
guangxi
medic
univers
affili
tumor
hospit
thirti
femal
mice
week
old
weigh
approxim
g
randomli
divid
three
group
follow
pb
group
adnc
empti
adenoviru
vector
group
vaccin
group
group
mice
subcutan
inject
back
mice
ul
mice
cervic
cancer
cell
express
fusion
protein
pb
adnc
vaccin
individu
administ
tattoo
day
cancer
cell
challeng
two
week
last
immun
serum
splenocyt
isol
individu
blood
spleen
immun
mice
peptid
use
antigen
activ
immun
mice
serum
splenocyt
elisa
elispot
assay
relat
serum
specif
antibodi
detect
enzymelink
immunosorb
assay
elisa
use
elisa
kit
follow
manufactur
instruct
dakew
biotech
co
ltd
splenocyt
detect
use
elispot
kit
dakew
biotech
co
ltd
briefli
nitrocellulos
plate
precoat
antimic
antibodi
place
overnight
block
follow
day
medium
contain
fb
immun
mice
splenocyt
ad
well
concentr
cellswel
volum
cell
stimul
peptid
plate
incub
carbon
dioxid
h
next
day
plate
incub
biotinyl
antimic
antibodi
primari
antibodi
h
room
temperatur
unbound
primari
antibodi
remov
wash
scrub
solut
streptavidinhrp
antibodi
secondari
antibodi
ad
follow
h
incub
room
temperatur
unbound
secondari
antibodi
remov
wash
scrub
solut
stain
aec
substrat
solut
carri
min
plate
wash
air
dri
h
immun
spot
repres
individu
cell
sfc
membran
enumer
kselispot
automat
system
dakew
biotech
co
ltd
product
associ
spot
indic
peptid
activ
mice
splenocyt
immum
vaccin
contain
gene
respons
consid
posit
spot
number
produc
vaccin
group
sfcwell
compar
respons
obtain
pb
group
adnc
group
pvalu
consid
signific
statist
analysi
spss
softwar
ibm
corp
armonk
ny
usa
use
statist
analys
ifnelispot
assay
elisa
evalu
use
analysi
varianc
anova
result
express
mean
standard
deviat
sd
identifi
signific
differ
group
student
ttest
use
comparison
p
consid
indic
statist
signific
differ
find
confirm
least
one
addit
independ
experi
peptid
predict
analysi
result
sever
peptid
predict
program
use
assist
identif
candid
ctl
epitop
accord
predict
result
three
program
toprank
six
peptid
select
shown
tabl
evalu
peptidespecif
cell
immun
human
pbmc
elispot
assay
perform
human
pbmc
use
final
concentr
candid
peptid
spot
detect
pha
posit
control
group
wherea
experiment
group
two
neg
control
group
neg
control
peptid
group
pb
group
exhibit
spot
format
fig
averag
number
spot
pha
neg
control
peptid
pb
group
respect
averag
number
spot
pha
group
significantli
higher
experi
group
two
neg
control
group
p
fig
humor
immunogen
peptid
day
last
immun
blood
collect
orbit
vein
mice
sera
isol
peptid
ad
plate
stimul
antigen
serum
mice
immun
pb
adnc
vaccin
ad
plate
specif
humor
immun
respons
associ
detect
elisa
elisa
complet
absorb
hole
hole
detect
absorb
valu
judg
posit
maximum
dilut
posit
result
regard
antibodi
titer
predict
peptid
shown
fig
day
last
immun
predict
peptid
antigen
vaccin
contain
protein
produc
specif
antibodi
immun
mice
serum
antibodi
titer
vaccin
group
antibodi
titer
pb
group
adnc
group
compar
two
control
group
antibodi
titer
vaccin
significantli
increas
p
peptid
activ
humor
immunogen
mice
immun
vaccin
contain
antigen
cellular
immunogen
peptid
test
cellular
immunogen
peptid
pbmc
immun
mice
isol
ad
plate
concentr
cellswel
volum
cell
stimul
peptid
uml
ad
cell
everi
day
splenocyt
cocultur
peptid
week
seven
day
later
splenocyt
immun
mice
test
directli
ex
vivo
elispot
assay
peptid
vaccin
induc
specif
cellular
immun
respons
peptid
mice
three
immun
averag
number
spot
posit
spot
signifi
cantli
increas
compar
neg
group
pb
p
adnc
empti
vector
p
fig
peptid
also
activ
cellular
immunogen
mice
immun
vaccin
contain
antigen
peptid
vaccin
attract
increas
attent
possess
abil
induc
singl
specif
immun
respons
present
studi
evalu
hpv
therapeut
polypeptid
vaccin
focus
hpv
protein
ctl
epitop
hpv
protein
contain
multipl
ctl
epitop
high
affin
hla
class
molecul
therefor
identifi
epitop
peptid
strong
immunogen
high
specif
process
key
prepar
hpv
therapeut
polypeptid
vaccin
despit
high
infect
rate
south
china
third
infect
rate
low
western
countri
moreov
infect
distribut
differ
region
research
develop
peptid
vaccin
receiv
much
attent
accept
ctl
epitop
identifi
date
thu
studi
develop
relat
therapeut
vaccin
difficult
specif
cellular
immun
mediat
ctl
play
key
role
cancer
immun
effector
cell
mainli
recogn
ctl
epitop
bound
mhci
molecul
induc
cytotox
cytotox
hlai
molecul
key
antigen
present
activ
cell
import
antigen
present
viru
antigen
tumor
antigen
specif
hlai
molecul
distribut
signific
ethnic
ethnic
geograph
differ
studi
shown
frequenc
allel
distribut
vari
differ
ethnic
group
account
approxim
chines
popul
termin
posit
amino
peptid
number
amino
acid
amino
acid
acid
sequenc
tlreyildl
dlhpeptdl
cinstttdv
stttdvrtl
tlqqllmgt
llmgtctiv
hpv
human
papilloma
viru
therefor
import
studi
ctl
epitop
peptid
chines
popul
present
ctl
epitop
protein
identifi
accept
present
mani
studi
confirm
effect
epitop
antigen
target
howev
studi
chan
identifi
three
peptid
amino
acid
posit
show
posit
respons
without
peptid
sabah
confirm
peptid
region
protein
rang
acid
epitop
ssdedeigl
potenti
cell
epitop
peptid
sequenc
could
interact
mani
seven
allel
show
popul
coverag
ctl
epitop
hpv
antigen
screen
acid
elut
use
synthet
overlap
peptid
howev
two
method
costli
time
consum
addit
method
result
high
miss
rate
four
eight
amino
acid
residu
separ
two
overlap
peptid
segment
time
money
save
use
intern
recogn
epitop
predict
site
therefor
studi
ctl
epitop
peptid
predict
use
sever
relat
websit
hla
bind
peptid
predict
websit
hla
peptid
bind
predict
http
wwwbimascitnih
govmolbiohlabind
syfpeith
http
wwwsyfpeithid
epitop
predict
analysi
tool
http
toolsimmun
epitopeorgmain
comprehens
analysi
preliminarili
identifi
ctl
antigen
peptid
subsequ
name
tlreyildl
dlhpeptdl
cinstttdv
stttdvrtl
tlqqllmgt
llmgtctiv
next
studi
pbmc
collect
cocultur
six
predict
peptid
respect
evalu
peptidespecif
cell
immun
human
pbmc
evid
elispot
assay
group
averag
number
spot
group
significantli
increas
compar
four
experi
group
two
neg
control
group
show
strongest
respons
therefor
chose
stttdvrtl
continu
studi
view
good
peptid
epitop
particular
sequenc
must
key
properti
firstli
epitop
fairli
well
conserv
among
hpv
proteom
secondli
epitop
capac
ensur
process
addit
process
peptid
abl
interact
mhc
allel
final
interact
mhc
allel
good
popul
coverag
chose
conserv
sequenc
fulfil
paramet
mention
antigen
verif
peptid
peptid
activ
humor
also
cellular
immun
reaction
vaccin
contain
antigen
neg
control
group
pb
adnc
antibodi
titer
vaccin
group
significantli
increas
cellular
immunoassay
averag
number
spot
vaccin
group
wa
significantli
enhanc
compar
pb
group
adnc
group
result
preliminarili
confirm
peptid
use
ctl
epitop
peptid
use
candid
peptid
peptid
vaccin
develop
overal
peptid
vaccin
consid
safe
easi
produc
stabl
howev
low
immunogen
must
first
overcom
anoth
limit
peptidebas
vaccin
need
match
patient
hla
make
difficult
develop
peptidebas
vaccin
applic
whole
popul
ctl
epitop
peptid
good
antigen
account
chines
popul
therefor
result
provid
potenti
target
epitop
protein
lay
foundat
construct
identif
peptid
vaccin
